Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business ProgressBusiness Wire • 4 days agoScholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases...